105 / 182
FIVE
| 101
Integrated Report 2016
ANNUAL FINANCIAL STATEMENTS
(continued)
SIX
THREE
ONE
FOUR
TWO
16. TRADE AND OTHER RECEIVABLES
(continued)
The maturity analysis of trade and other receivables is as follows:
Trade Receivables
Neither past due nor impaired
<30 days
723 313
654 479
31 – 60 days
448 237
425 452
61 – 90 days
95 293
84 291
Past due after impairments
91 – 180 days
40 982
52 557
>180 days
12 666
7 228
Total
1 320 491
1 224 007
Sundry Receivables
Neither past due nor impaired
<30 days
17 067
38 912
31 – 60 days
8 241
13 492
61 – 90 days
2 788
4 373
>90 days
16 697
8 023
Total
44 793
64 800
Details in respect of the Group’s credit risk management policies are set out in Annexure E. The
directors consider that the carrying amount of the trade and other receivables approximates their fair
value due to the short period to maturity.
17. CASH AND CASH EQUIVALENTS/OVERDRAFT
Cash at banks
200 555
147 379
Bank overdraft
(11 755)
(304 210)
188 800
(156 831)
Cash at banks earns interest at floating rates based on daily bank deposit rates. Overdraft balances in
South Africa incur interest at 8.0%.
The fair value of the net bank overdraft approximates R188.8 million (2015: R156.8 million).
There are no restrictions over the cash balances and all balances are available for use.
Property, plant and equipment to the value of R40.5 million in Datlabs have been pledged as security
for the bank overdraft of R11.8 million. Refer to note 10. In the prior year property, plant and equipment
to the value of R35.6 million in Datlabs and R17.1 million in Ghana were pledged as security for the
bank overdrafts of R13.7 million and R11.0 million respectively.
For the purposes of the statement of cash flows, the Group’s cash and cash equivalents at the end of
the year includes the following:
Adcock Ingram Private Limited (India)
117 618
Ayrton Drug Manufacturing Limited (Ayrton)
(11 956)
Cash at banks and short-term deposits attributable to the discontinued operations
105 662
2016
R’000
2015
R’000